51 – 60 of 157
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Alemtuzumab as Remission Induction Therapy in Behçet Disease: A 20-year Experience.
(
- Contribution to journal › Article
-
Mark
Sustained Remission in Tumor Necrosis Factor Inhibitor-treated Patients with Rheumatoid Arthritis: A Population-based Cohort Study.
(
- Contribution to journal › Article
- 2014
-
Mark
Further evidence for influenza and pneumococcal vaccination in patients treated with disease modifying antirheumatic drugs and anti-tumor necrosis factor agents.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Worker Productivity Outcome Measures: OMERACT Filter Evidence and Agenda for Future Research
(
- Contribution to journal › Article
-
Mark
Prevalence, Correlates and Outcomes of Gastric Antral Vascular Ectasia in Systemic Sclerosis: A EUSTAR Case-control Study.
(
- Contribution to journal › Article
-
Mark
Development of a Modified Hand Mobility in Scleroderma (HAMIS) Test and its Potential as an Outcome Measure in Systemic Sclerosis.
(
- Contribution to journal › Article
-
Mark
American College of Rheumatology Criteria at Inception, and Accrual over 5 Years in the SLICC Inception Cohort.
(
- Contribution to journal › Article
-
Mark
Belimumab in systemic lupus erythematosus -- what can be learned from longterm observational studies?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Comparison of phenotype and outcome in microscopic polyangiitis between europe and Japan.
(
- Contribution to journal › Article
-
Mark
A Population-based Study Showing Better Renal Prognosis for Proteinase 3 Antineutrophil Cytoplasmic Antibody (ANCA)-associated Nephritis Versus Myeloperoxidase ANCA-associated Nephritis.
(
- Contribution to journal › Article